Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-10 4:36 pm Purchase | 2025-12-03 | 13G | Astria Therapeutics, Inc. ATXS | GLAZER CAPITAL, LLC | 3,155,200 5.530% | 3,155,200 (New Position) | Filing History |
| 2025-11-14 4:02 pm Purchase | 2025-09-30 | 13G | Astria Therapeutics, Inc. ATXS | Vestal Point Capital, LP | 4,956,000 8.800% | 956,000 (+23.90%) | Filing History |
| 2025-11-14 09:46 am Sale | 2025-10-16 | 13G | Astria Therapeutics, Inc. ATXS | ForGrowth III PA B.V. | 0 0.000% | -3,822,537 (Position Closed) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 1,251,766 2.200% | -3,902,148 (-75.71%) | Filing History |
| 2025-11-05 11:26 am Sale | 2025-09-30 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 5,153,914 9.100% | -1,782,852 (-25.70%) | Filing History |
| 2025-10-24 11:00 am Purchase | 2025-10-17 | 13D | Astria Therapeutics, Inc. ATXS | Magnetar Financial LLC | 3,312,202 5.870% | 3,312,202 (New Position) | Filing History |
| 2025-10-20 4:23 pm Sale | 2025-10-14 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 222,101 0.400% | -2,715,702 (-92.44%) | Filing History |
| 2025-10-16 8:52 pm Unchanged | 2025-10-14 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 6,485,420 11.500% | 0 (Unchanged) | Filing History |
| 2025-10-15 09:27 am Sale | 2025-10-14 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 2,377,049 4.000% | -3,491,988 (-59.50%) | Filing History |
| 2025-08-14 5:56 pm Sale | 2025-06-30 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,105,213 (Position Closed) | Filing History |
| 2025-06-18 4:03 pm Purchase | 2025-06-13 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 2,937,803 5.200% | 943,300 (+47.29%) | Filing History |
| 2025-05-15 08:45 am Purchase | 2025-03-31 | 13G | Astria Therapeutics, Inc. ATXS | ForGrowth III PA B.V. | 3,822,537 6.800% | 950,000 (+33.07%) | Filing History |
| 2025-05-12 10:10 am Sale | 2025-03-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 6,936,766 12.300% | -886,963 (-11.34%) | Filing History |
| 2025-02-14 6:13 pm Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III, L.P. | 2,457,348 4.400% | -1,001,297 (-28.95%) | Filing History |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 5,869,037 9.900% | 992 (+0.02%) | Filing History |
| 2025-02-12 08:46 am Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 7,823,729 13.900% | -639,949 (-7.56%) | Filing History |
| 2025-01-28 4:00 pm Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 1,994,503 3.500% | -954,373 (-32.36%) | Filing History |
| 2025-01-07 07:45 am Purchase | 2024-12-30 | 13G | Astria Therapeutics, Inc. ATXS | ForGrowth III PA B.V. | 2,872,537 5.100% | 2,872,537 (New Position) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 5,105,213 9.000% | 692,063 (+15.68%) | Filing History |
| 2024-11-14 5:45 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III, L.P. | 3,458,645 6.100% | 232,839 (+7.22%) | Filing History |